Concepedia

Dmitry R. Gumerov

DR

Statistics

Publications

14

Citations

775

H-Index

14

Active since

2001

Affiliations

Mersana Therapeutics (United States)(Current)

University of Massachusetts Amherst

University of Vermont

University of British Columbia

University of Vermont Medical Center

Dmitry R. Gumerov is an author at Mersana Therapeutics (United States) specializing in biochemistry, pharmacology, and analytical chemistry.

Publications per year

2001–2021

14

Publications

14

Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry

Jun Han, Ryan M. Danell, Jayanti R. Patel et al. · Metabolomics · 2008 · 147 citations · Full text

, , +11

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 100 citations

, , +17

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 75 citations · Full text

, , +17

Electron transfer dissociation in the hexapole collision cell of a hybrid quadrupole‐hexapole Fourier transform ion cyclotron resonance mass spectrometer

Desmond A. Kaplan, Ralf Hartmer, J. Paul Speir et al. · Rapid Communications in Mass Spectrometry · 2008 · 66 citations

, , +16

Differential Effect of a His Tag at the N- and C-Termini:  Functional Studies with Recombinant Human Serum Transferrin

Anne B. Mason, Qing‐Yu He, Peter J. Halbrooks et al. · Biochemistry · 2002 · 59 citations

, , +11

1–5 of 14